Aurinia Pharmaceuticals Inc. Banner Image

Aurinia Pharmaceuticals Inc.

  • Ticker AUPH
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Aurinia Pharmaceuticals Inc. Logo Image
  • 201-500 Employees
  • Based in Victoria, British Columbia
Aurinia Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are suffering from serious diseases with a high unmet medical need. The company is currently developing voclosporin, an investigational drug, for the potential treatment of lupus nephritis and Dry Eye Syndrome. The company isMore headquartered in Victoria, British Columbia, its U.S. commercial hub in Rockville, MD, and focuses its development efforts globally.
4.8 / 5.0 (84)

Aurinia Pharmaceuticals Inc. reports have an aggregate usefulness score of 4.8 based on 84 reviews.

Aurinia Pharmaceuticals Inc.

Most Recent Annual Report

Aurinia Pharmaceuticals Inc.
MOST RECENT 2022 Annual Report and Form 10K

Older/Archived Annual Reports

Aurinia Pharmaceuticals Inc. Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!